In this Webinar:

What was once an altruistic option is becoming a regulatory mandate. With the FDA’s recent guidance on Diversity Action Plans for clinical trials, we’ve entered a new era for clinical research that aims to increase representativeness across race, ethnicity, sex, age and other groups. To get there, trial sponsors will need to rely on real-world data more than ever before.

Tracy Ohrt, Director of Clinical Operations at Optum Life Sciences, and Jenny Higley, Director, Feasibility Center of Excellence at Biogen, will discuss the ways real-world data can help sponsors embrace the challenge and improve both access and outcomes. By designing better studies and matching the right individuals to trial opportunities, sponsors can increase participation, diversity, and representation, and ultimately bring better care to populations that need it.

Featured Topics:

• Increasing representativeness in clinical trials

• Understanding patient populations

• Developing Diversity Action Plans using real-world data

• Tracy Ohrt, MS, BS, PMP, CCRA, CCRC
  Director, Clinical Operations, Digital Research Network
  

• Jenny Higley
  Director, Feasibility Center of Excellence at Biogen